Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Feb 25, 2019 Theratechnologies Acquires Targeted Oncology Company Katana Biopharma Inc. Feb 21, 2019 Theratechnologies Announces Financial Results for Fiscal Year 2018 Feb 11, 2019 Theratechnologies Appoints General Manager in Europe Feb 11, 2019 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2018 Dec 03, 2018 THERATECHNOLOGIES APPOINTS NEW CHIEF COMMERCIAL OFFICER Nov 27, 2018 THERATECHNOLOGIES’ CFO TO PRESENT AT 30TH ANNUAL PIPER JAFFRAY AND AT BMO HEALTHCARE CONFERENCES Nov 08, 2018 Specific Billing J-Code Issued for Trogarzo® by Center for Medicare and Medicaid Services Nov 05, 2018 FDA Approves Novel Single-Vial Formulation of Egrifta® Oct 31, 2018 Trogarzo® Phase III Data Analysis featured During Late-Breaking Oral Presentation at HIV Drug Therapy Glasgow 2018 Oct 30, 2018 Trogarzo® Phase III Data Analysis Presented at HIV Drug Therapy Glasgow 2018: Patients not achieving primary endpoint at day 7 experienced clinical benefit by end of study First page « Previous page ‹ … Page 18 Page 19 Page 20 Page 21 Current page 22 Page 23 Page 24 Page 25 Page 26 … Next page › Last page » Displaying 211 - 220 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Nov 27, 2018 THERATECHNOLOGIES’ CFO TO PRESENT AT 30TH ANNUAL PIPER JAFFRAY AND AT BMO HEALTHCARE CONFERENCES
Nov 08, 2018 Specific Billing J-Code Issued for Trogarzo® by Center for Medicare and Medicaid Services
Oct 31, 2018 Trogarzo® Phase III Data Analysis featured During Late-Breaking Oral Presentation at HIV Drug Therapy Glasgow 2018
Oct 30, 2018 Trogarzo® Phase III Data Analysis Presented at HIV Drug Therapy Glasgow 2018: Patients not achieving primary endpoint at day 7 experienced clinical benefit by end of study